<code id='4729C5581D'></code><style id='4729C5581D'></style>
    • <acronym id='4729C5581D'></acronym>
      <center id='4729C5581D'><center id='4729C5581D'><tfoot id='4729C5581D'></tfoot></center><abbr id='4729C5581D'><dir id='4729C5581D'><tfoot id='4729C5581D'></tfoot><noframes id='4729C5581D'>

    • <optgroup id='4729C5581D'><strike id='4729C5581D'><sup id='4729C5581D'></sup></strike><code id='4729C5581D'></code></optgroup>
        1. <b id='4729C5581D'><label id='4729C5581D'><select id='4729C5581D'><dt id='4729C5581D'><span id='4729C5581D'></span></dt></select></label></b><u id='4729C5581D'></u>
          <i id='4729C5581D'><strike id='4729C5581D'><tt id='4729C5581D'><pre id='4729C5581D'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:4387
          Sammy Kimball for STAT

          Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

          advertisement

          For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          leisure time

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy